Ezetimibe Added to Statin Therapy (EASY) Study (0653-087)(COMPLETED)

PHASE3CompletedINTERVENTIONAL
Enrollment

141

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

November 30, 2005

Study Completion Date

November 30, 2005

Conditions
Hypercholesterolemia
Interventions
DRUG

MK0653, ezetimibe / Duration of Treatment: 6 Weeks

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00395473 - Ezetimibe Added to Statin Therapy (EASY) Study (0653-087)(COMPLETED) | Biotech Hunter | Biotech Hunter